Beijing Strong Biotechnologies Inc
SZSE:300406
Beijing Strong Biotechnologies Inc
Capital Expenditures
Beijing Strong Biotechnologies Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
Capital Expenditures
-¥153.4m
|
CAGR 3-Years
-99%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Capital Expenditures
-¥4.1B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Capital Expenditures
-¥1.4B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Capital Expenditures
-¥1.2B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Capital Expenditures
-¥1.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-18%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Capital Expenditures
-¥155.7m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Strong Biotechnologies Inc's Capital Expenditures?
Capital Expenditures
-153.4m
CNY
Based on the financial report for Mar 31, 2024, Beijing Strong Biotechnologies Inc's Capital Expenditures amounts to -153.4m CNY.
What is Beijing Strong Biotechnologies Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-15%
Over the last year, the Capital Expenditures growth was -55%. The average annual Capital Expenditures growth rates for Beijing Strong Biotechnologies Inc have been -99% over the past three years , -15% over the past five years .